Evidence map›Paper›PMID 34289895›Full record

ArticleActa neuropathologica communications2021

Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions.

L E M Wisse, S Ravikumar, R Ittyerah, S Lim, J Lane, M L Bedard, L Xie, S R Das, T Schuck, M Grossman and 20 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Brain morphometry patterns in the presence of Alzheimer's disease and/or LATE neuropathologic changes.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Tau, atrophy, and domain-specific cognitive impairment in typical Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  13. Article
  14. Article
  15. Heterogeneous tau deposition patterns in the preclinical stage link to domain-specific cognitive deficits.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  16. Amygdala atrophies in specific subnuclei in preclinical Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 5 institutions in 3 countries.

L E M Wisse *Department of Diagnostic Radiology, Lund University, Klinikgatan 13b, Lund, Sweden. lemwisse@gmail.com.ORCID 0000-0001-7504-3943
S Ravikumar *Department of Radiology, University of Pennsylvania, Philadelphia, USA.
R IttyerahDepartment of Radiology, University of Pennsylvania, Philadelphia, USA.
S LimDepartment of Radiology, University of Pennsylvania, Philadelphia, USA.
J LaneDepartment of Neurology, University of Pennsylvania, Philadelphia, USA.
M L BedardDepartment of Pharmacology, University of North Carolina At Chapel Hill, Chapel Hill, USA.
L XieDepartment of Radiology, University of Pennsylvania, Philadelphia, USA.
S R DasDepartment of Neurology, University of Pennsylvania, Philadelphia, USA.
T SchuckCenter for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, USA.
M GrossmanDepartment of Neurology, University of Pennsylvania, Philadelphia, USA.
E B LeeCenter for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, USA.
M D TisdallDepartment of Radiology, University of Pennsylvania, Philadelphia, USA.
K PrabhakaranDepartment of Neurology, University of Pennsylvania, Philadelphia, USA.
J A DetreDepartment of Neurology, University of Pennsylvania, Philadelphia, USA.
G MizseiDepartment of Radiology, University of Pennsylvania, Philadelphia, USA.
J Q TrojanowskiCenter for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, USA.
E Artacho-PérulaHuman Neuroanatomy Laboratory, Neuromax CSIC Associated Unit, University of Castilla La Mancha, Albacete, Spain.
M M de Iñiguez de Onzono MartinHuman Neuroanatomy Laboratory, Neuromax CSIC Associated Unit, University of Castilla La Mancha, Albacete, Spain.
M M Arroyo-JiménezHuman Neuroanatomy Laboratory, Neuromax CSIC Associated Unit, University of Castilla La Mancha, Albacete, Spain.
M Muñoz LopezHuman Neuroanatomy Laboratory, Neuromax CSIC Associated Unit, University of Castilla La Mancha, Albacete, Spain.
F J Molina RomeroHuman Neuroanatomy Laboratory, Neuromax CSIC Associated Unit, University of Castilla La Mancha, Albacete, Spain.
M P Marcos RabalHuman Neuroanatomy Laboratory, Neuromax CSIC Associated Unit, University of Castilla La Mancha, Albacete, Spain.
S Cebada SánchezHuman Neuroanatomy Laboratory, Neuromax CSIC Associated Unit, University of Castilla La Mancha, Albacete, Spain.
J C Delgado GonzálezHuman Neuroanatomy Laboratory, Neuromax CSIC Associated Unit, University of Castilla La Mancha, Albacete, Spain.
C de la Rosa PrietoHuman Neuroanatomy Laboratory, Neuromax CSIC Associated Unit, University of Castilla La Mancha, Albacete, Spain.
M Córcoles ParadaHuman Neuroanatomy Laboratory, Neuromax CSIC Associated Unit, University of Castilla La Mancha, Albacete, Spain.
D A WolkDepartment of Neurology, University of Pennsylvania, Philadelphia, USA.
D J IrwinDepartment of Neurology, University of Pennsylvania, Philadelphia, USA.
R InsaustiHuman Neuroanatomy Laboratory, Neuromax CSIC Associated Unit, University of Castilla La Mancha, Albacete, Spain.
P A YushkevichDepartment of Radiology, University of Pennsylvania, Philadelphia, USA.
University of Pennsylvania · USUniversity of Castilla-La Mancha · ESInstitute for Neurodegenerative Disorders · USLund University · SEUniversity of North Carolina at Chapel Hill · US

Funding

Transgenic Mouse Models of Tau PathologiesP01AG017586 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2000 to 2021
$37.3M
UPenn ADCC Biomarker CoreP30AG010124 · NIA · UNIVERSITY OF PENNSYLVANIA · PI XIE, SHARON XIANGWEN · 1991 to 2020
$35.1M
Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAVID A WOLK · 2021 to 2026
$24.8M
Ex Vivo Imaging of the Aging Brain to Discover Morphology/Pathology AssociationsR01AG056014 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Paul A. Yushkevich · 2017 to 2026
$4.5M
Modulators of Medial Temporal Lobe Subregion Structure and Function in Normal and Pathological AgingR01AG055005 · NIA · UNIVERSITY OF PENNSYLVANIA · PI WOLK, DAVID A · 2017 to 2021
$3.3M
NIA NIH HHS P01 AG017586NIA NIH HHS P30 AG010124NIA NIH HHS P30 AG072979NIA NIH HHS R01 AG055005NIA NIH HHS R01 AG056014
6 · The paper itself

Abstract

The medial temporal lobe (MTL) is a nidus for neurodegenerative pathologies and therefore an important region in which to study polypathology. We investigated associations between neurodegenerative pathologies and the thickness of different MTL subregions measured using high-resolution post-mortem MRI. Tau, TAR DNA-binding protein 43 (TDP-43), amyloid-β and α-synuclein pathology were rated on a scale of 0 (absent)-3 (severe) in the hippocampus and entorhinal cortex (ERC) of 58 individuals with and without neurodegenerative diseases (median age 75.0 years, 60.3% male). Thickness measurements in ERC, Brodmann Area (BA) 35 and 36, parahippocampal cortex, subiculum, cornu ammonis (CA)1 and the stratum radiatum lacunosum moleculare (SRLM) were derived from 0.2 × 0.2 × 0.2 mm

Indexed as

AdultAgedAged, 80 and overalpha-SynucleinAlzheimer DiseaseAmyloid beta-PeptidesBrain Cortical ThicknessCA1 Region, HippocampalCase-Control StudiesDNA-Binding ProteinsEntorhinal CortexFemaleFrontotemporal Lobar DegenerationHippocampusHumansLewy Body Diseasealpha-SynucleinAmyloid beta-PeptidesDNA-Binding ProteinsMAPT protein, humanSNCA protein, humanTARDBP protein, humantau Proteins

Identifiers

PMID34289895
PMCPMC8293481
OpenAlexW3184219868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.